IL-6 augments the invasiveness of U87MG human glioblastoma multiforme cells via up-regulation of MMP-2 and fascin-1

Oncology Reports

Volumn 23, Issue 6, 2010, Pages 1553-1559

  Li, Ronghui ^a   Li, Gang ^a   Deng, Lin ^a   Liu, Qinglin ^a   Dai, Jun ^b   Shen, Jie ^a   Zhang, Jian ^b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Fascin 1; Glioma; IL 6; Invasiveness; MMP 2; STAT3

Indexed keywords

FASCIN; FASCIN 1; GELATINASE A; INTERLEUKIN 6; SMALL INTERFERING RNA; STAT3 PROTEIN; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; CARRIER PROTEIN; FSCN1 PROTEIN, HUMAN; MESSENGER RNA; STAT3 PROTEIN, HUMAN;

ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; UPREGULATION; ANTAGONISTS AND INHIBITORS; BRAIN TUMOR; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; TUMOR INVASION; WESTERN BLOTTING;

BLOTTING, WESTERN; BRAIN NEOPLASMS; CARRIER PROTEINS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; GLIOBLASTOMA; HUMANS; INTERLEUKIN-6; MATRIX METALLOPROTEINASE 2; MICROFILAMENT PROTEINS; NEOPLASM INVASIVENESS; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; STAT3 TRANSCRIPTION FACTOR; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 77951735629     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000795     Document Type: Article

References (28)

1. Fomchenko EI and Holland EC: Mouse models of brain tumors and their applications in preclinical trials. Clin Cancer Res 12: 5288-5297, 2006.
2. Chen SH, Gillespie GY and Benveniste EN: Divergent effects of oncostatin M on astroglioma cells: influence on cell proliferation, invasion and expression of matrix metalloproteinases. Glia 53: 191-200, 2006.
3. Lonser RR, Walbridge S, Vortmeyer AO, et al: Induction of glioblastoma multiforme in non-human primates after therapeutic doses of fractionated whole-brain radiation therapy. J Neurosurg 97: 1378-1389, 2002.
4. Bello L, Giussani C, Carrabba G, et al: Suppression of malignant glioma recurrence in a newly developed animal model by endogenous inhibitors. Clin Cancer Res 8: 3539-3548, 2002.
5. Rubenstein JL, Kim J, Ozawa T, Zhang M, Westphal M, Deen DF and Shuman MA: Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia 2: 306-314, 2000.
6. Steeg PS: Angiogenesis inhibitors: motivators of metastasis? Nat Med 9: 822-823, 2003.
7. Hong DS, Angelo LS and Kurzrock R: Interleukin-6 and its receptor in cancer: implications for translational therapeutics. Cancer 110: 1911-1928, 2007.
8. Hsu CP and Chung YC: Influence of interleukin-6 on the invasiveness of human colorectal carcinoma. Anticancer Res 26: 4607-4614, 2006.
9. Kanazawa T, Nishino H, Hasegawa M, Ohta Y, Iino Y, Ichimura K and Noda Y: Interleukin-6 directly influences proliferation and invasion potential of head and neck cancer cells. Eur Arch Otorhinolaryngol 264: 815-821, 2007.
10. Van Meir E, Sawamura Y, Diserens AC, Hamou MF and De Tribolet N: Human glioblastoma cells release interleukin 6 in vivo and in vitro. Cancer Res 50: 6683-6688, 1990.
11. Weissenberger J, Loeffler S, Kappeler A, et al: IL-6 is required for glioma development in a mouse model. Oncogene 23: 3308-3316, 2004.
12. Rolhion C, Penault-Llorca F, Kemeny JL, et al: Interleukin-6 overexpression as a marker of malignancy in human gliomas. J Neurosurg 94: 97-101, 2001.
13. Tchirkov A, Khalil T, Chautard E, et al: Interleukin-6 gene amplification and shortened survival in glioblastoma patients. Br J Cancer 96: 474-476, 2007.
14. Chang CY, Li MC, Liao SL, Huang YL, Shen CC and Pan HC: Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme. J Clin Neurosci 12: 930-933, 2005.
15. Loeffler S, Fayard B, Weis J and Weissenberger J: Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between stat3 and sp1. Int J Cancer 115: 202-213, 2005.
16. Kossakowska AE, Edwards DR, Prusinkiewicz C, et al: Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas. Blood 94: 2080-2089, 1999.
17. Xie TX, Wei D, Liu M, et al: Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene 23: 3550-3560, 2004.
18. Grothey A, Hashizume R, Ji H, et al: C-erbb-2/her-2 up-regulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines. Oncogene 19: 4864-4875, 2000.
19. Hashimoto Y, Skacel M and Adams JC: Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Int J Biochem Cell Biol 37: 1787 - 1804, 2005.
20. Gunal A, Onguru O, Safali M and Beyzadeoglu M: Fascin expression in glial tumors and its prognostic significance in glioblastomas. Neuropathology 28: 382-386, 2008.
21. Hwang JH, Smith CA, Salhia B and Rutka JT: The role of fascin in the migration and invasiveness of malignant glioma cells. Neoplasia 10: 149-159, 2008.
22. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498, 2001.
23. Goswami S, Gupta A and Sharma SK: Interleukin-6-mediated autocrine growth promotion in human glioblastoma multiforme cell line U87 MG. J Neurochem 71: 1837-1845, 1998.
24. Rao JS: Molecular mechanisms of glioma invasiveness: the role of proteases. Nature Rev 3: 489-501, 2003.
25. Huang C, Cao J, Huang KJ, Zhang F, Jiang T, Zhu L and Qiu ZJ: Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cells in vitro. Cancer Sci 97: 1417-1423, 2006.
26. Su Y, Li G, Zhang X, Gu J, Zhang C, Tian Z and Zhang J: JSI-124 inhibits glioblastoma multiforme cell proliferation through G(2)/m cell cycle arrest and apoptosis augment. Cancer Biol Ther 7: 1243-1249, 2008.
27. Iwamaru A, Szymanski S, Iwado E, et al: A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo. Oncogene 26: 2435-2444, 2007.
28. Schaefer LK, Ren Z, Fuller GN and Schaefer TS: Constitutive activation of STAT3alpha in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2). Oncogene 21: 2058-2065, 2002.